Technical aspects
We resected as much pericardium as it covers to the
left anterior and left lateral of the heart, by preserving
the left phrenic nerve integrity. The pericardium was
stretched on a flat surgical panel using silk sutures
and it was embedded into the glutaraldehyde solution.
Aorta-bicaval cannulation, total cardiopulmonary
bypass, and cross-clamping were done sequentially.
The bovine patch over the pulmonary artery was
unstitched until 2 cm to the PV remnants. The
surgical field was widened by extending the incision
transversely and putting stay sutures. The remaining
valve remnants were excised.
First, we drew two circles inside the pulmonary trunk which were 1.5-cm away from each other to imitate the aortic annulus anatomy (Figure 1). The proximal circle close to the RV would be for the base of leaflets, and the distal one was for the tip of the commissures. A silk string was lied over the distal circle to measure the circumference (C) and the radius (r) of the coaptation plane of the leaflets with the following formula: r=C/2π. Each circle was divided to three equal pieces in a manner that each dividing-mark on the proximal circle corresponded to center of distal one third of piece. Again, we drew semicircles on the luminal surface of the pulmonary trunk to connect one mark on distal circle to the adjacent one, while the base of semicircles touched to the dividing marks on the proximal circle.
Figure 1: Imitation of aortic root into pulmonary artery.
Secondly, we made a handmade template on a sterile paper-based surgical towel. We drew a square with an edge-length equal to "R" (R=1.71¥r). A complete circle with diameter of R was drawn into that square. Then, we drew the line "a" to the center of this square on the vertical axis to measure the height of the template (a=0.8¥r). We delineated the free-margins of the cusp by drawing two lines starting from the tip of the line-a to the lateral margins of the square. Since those would be coapting free-margins, each should be exactly as long as "r" of the pulmonary trunk. The template was ready to cut (bold line on Figure 2). We copied all three leaflets from the same template. However, to preserve the coapting margins in correct length, we cut the template in such a manner that the lateral connections had additional stitching pieces at each site (Figure 2) as described by Ozaki et al.[3] We used 5/0 prolene sutures to sew the leaflets to the new pulmonary root starting from the central mark on the proximal circle throughout corresponding semicircle and ending at the mark on distal circle (Figure 1).
After finishing PV reconstruction (Figure 3), pulmonary arteriotomy was closed and weaning from cardiopulmonary bypass was performed ordinarily. Intraoperative TEE and control TTE after extubation revealed that new PV had a trace amount of reflux and minimal pressure gradient (maximum gradient 13.8 mmHg) (Figure 4a, b).
The gold standard for reconstruction of the right ventricular outflow tract is a pulmonary homograft.[6] To the best of our knowledge, this case is the only trileaflet autograft reconstruction in the literature. The leaflet mobility and adaptation to the hemodynamics of the right ventricular outflow tract seems to be excellent in a short time period. Since the autografts do not induce immune response, graft rejection would not be the probable cause of dysfunction. Rather than immunogenicity, hemodynamic stress should be considered in pulmonary valve which has less pressure gradient than the aortic root where it provides good short- and mid-term results with good hemodynamics and good quality of life without anticoagulation.[3] Regarding the superior event-free survival of patients with pulmonary homograft,[6] it may be reasonable to expect at least same similar favorable outcomes of PV constructed from autologous pericardium. The followup of the patient with more cases would definitely help to overcome suspicions.
Except the wasted peripheral region, we used about 21 cm2 of pericardium in our case. If a satisfactory asymptomatic period would be achieved, and if needed in the future, it seems to be reproducible option for subsequent reconstruction of PV with remaining pericardium. Moreover, unlike the fabricated homografts, intended sizes could be constructed on-table with this template formula.
In conclusion, if expected favorable outcomes can be achieved with follow-up of such rare cases, this type of reconstruction technique would open a wide scope for on-table production of pulmonary valve in patients with pulmonary valve dysfunction late after tetralogy of Fallot operations and totally autologous aortic root reconstruction or hybrid root operations with pericardial valve leaflets in the aortic valve endocarditis.
Declaration of conflicting interests
The author declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The author received no financial support for the research
and/or authorship of this article.
EDITORIAL COMMENT
Cem Alhan
In the 1950s, Dr. Dwight Emary Harken defined Ten
Commandments for the prosthetic valve as follows:[1]
1. It must not propagate emboli. 2. It must be chemically inert and not damage blood elements. 3. It must offer no resistance to physiological flows. 4. It must close promptly (less than 0.05 second). 5. It must remain closed during the appropriate phase of the cardiac cycle. 6. It must have lasting physical and geometric features. 7. It must be inserted in a physiological site (generally the normal anatomic site). 8. It must be capable of permanent fixation. 9. It must not annoy the patient. 10. It must be practical to insert.
Indeed, we can add one more commandment that is it must not obstruct or damage neighboring structures (i.e., coronary ostia, atrioventricular node [AV] node).
After more than six decades, we can easily state that these properties have not been fully met yet, and there is no ideal prosthetic valve. There is an apparent limitation of durability with bioprosthetic valves and an apparent disadvantage of anticoagulation with mechanical prostheses. On the other hand, hemodynamic properties (i.e., effective orifice area and transvalvular gradient) of prosthetic valves are worse, compared to native valves. Therefore, severe improvements have been achieved in aortic valve repair in the last five decades. Aortic valve repair using autologous pericardial cusp extension has been described by Duran and associates.[2] Halees et al.[3] in their 16-year follow-up of aortic valve reconstruction showed that the mode of valve degeneration differs between the bovine pericardium and the autologous pericardium. The failed bovine pericardial valves tended to show heavy calcification and extensive fibrosis which made the reoperation technically more difficult than with the autologous pericardium, showing still pliability with less fibrosis and calcification.
Neo-cuspidization either in aortic or pulmonary position[4] is probably the most optimal alternative to mechanical or bioprosthetic replacement due to its superior hemodynamic properties such as largest effective orifice area, least transvalvular gradient. In addition, no foreign material is used and AV block incidence is almost zero. Another advantage of neocuspidization is the avoidance of anticoagulation. Only low-dose aspirin is usually given for three months postoperatively.
The only, but probably the most important drawback of neo-cuspidization is its durability. In a recent study, Ozaki et al.[5] r eported t heir e xperience i n 850 consecutive patients operated for aortic stenosis, some of them with additional procedures (43.6%). The median age was 71 years and the mean follow-up was 53.7±28.2 months. Actuarial freedom from death, cumulative incidence of reoperation, and that of recurrent moderate-to-severe aortic regurgitation was 85.9%, 4.2%, and 7.3%, respectively, with the longest follow-up of 118 months. The authors reported no conversion to a prosthetic valve replacement and only one case out of 850 underwent reoperation for structural valve degeneration.
These results seem to be consistent with the clinical outcomes of all current prosthetic valves. In pediatric patients and in specific cases such as patients with small aortic annulus, this technique may provide additional benefits.
REFERENCES
1. Harken DE. Heart valves: Ten commandments and still
counting. Ann Thorac Surg 1989;48:518-9.
2. Duran CM, Gometza B, Kumar N, Gallo R, Martin-Duran
R. Aortic valve replacement with freehand autologous
pericardium. J Thorac Cardiovasc Surg 1995;110:511-6.
3. Al Halees Z, Al Shahid M, Al Sanei A, Sallehuddin
A, Duran C. Up to 16 years follow-up of aortic valve
reconstruction with pericardium: a stentless readily
available cheap valve? Eur J Cardiothorac Surg
2005;28:200-5.
4. Kahraman D. Trileaflet reconstruction of pulmonary valve
for acute pulmonary valve insufficiency. Turk Gogus Kalp
Dama 2019;27:219-23.
5. Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh
M, Kiyohara N. Midterm outcomes after aortic valve
neocuspidization with glutaraldehyde-treated autologous
pericardium. J Thorac Cardiovasc Surg 2018;155:2379-87.
Correspondence: Cem Alhan, MD. Acıbadem Maslak Hastanesi
Kalp ve Damar Cerrahisi Bölümü, 34457 Maslak, İstanbul, Turkey.
Tel: +90 212 - 304 48 95 e-mail: profdrcemalhan@gmail.com
1) Shin YR, Park HK, Park YH, Jung JW, Kim YJ, Shin
HJ. Pulmonary valve cusp augmentation for pulmonary
regurgitation after repair of valvular pulmonary stenosis.
Ann Thorac Surg 2015;99:57-8.
2) Bhagra CJ, Hickey EJ, Van De Bruaene A, Roche SL,
Horlick EM, Wald RM. Pulmonary Valve Procedures Late
After Repair of Tetralogy of Fallot: Current Perspectives and
Contemporary Approaches to Management. Can J Cardiol
2017;33:1138-49.
3) Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y,
Matsuyama T, et al. Aortic valve reconstruction using selfdeveloped
aortic valve plasty system in aortic valve disease.
Interact Cardiovasc Thorac Surg 2011;12:550-3.
4) Ilbawi MN, Lockhart CG, Idriss FS, DeLeon SY, Muster
AJ, Duffy CE, et al. Experience with St. Jude Medical valve
prosthesis in children. A word of caution regarding rightsided
placement. J Thorac Cardiovasc Surg 1987;93:73-9.